Jesjeet Singh GILL, Subash Kumar PILLAI, Koh Ong HUI, Stephen Thevanathan JAMBUNATHAN, Rusdi Abdul RASHID, Ahmad Hatim SULAIMAN

A 3-week, open label study to evaluate the efficacy and safety of extended release quetiapine fumarate in the treatment of agitation in patients with schizophrenia

Şizofreni hastalarında ajitasyonun tedavi- sinde uzamış salınımlı ketiyapin fumarat’ın etkinlik ve güvenliği: 3 haftalık, açık etiketli bir çalışma

Klinik Psikofarmakoloji Bülteni

2013-Cilt: 23 - Sayı: 1

14-23

146

Benzer Makaleler

Sodium and depression: Hypothetical associations

Klinik Psikofarmakoloji Bülteni

Osman OZDEMİR

Critiques and challenges to old and recently proposed American Psychiatric Association’s website DSM 5 diagnostic criteria for sexual dysfunctions

Klinik Psikofarmakoloji Bülteni

Z. Mehmet SUNGUR, Anil GUNDUZ

Asenapine: A novel hope in the treatment of schizophrenia and manic and mixed episodes of bipolar I disorder

Klinik Psikofarmakoloji Bülteni

Mesut CETİN

Fluoxetine- and sertraline-related hair loss in a teenager: A case report

Klinik Psikofarmakoloji Bülteni

Serhat TURKOGLU

Disulfiram implantation in alcohol dependency: influence of sociodemographic and clinical variables on treatment response

Klinik Psikofarmakoloji Bülteni

Ozhan YALCIN, Numan KONUK, Asli Akin ASLAN, Behcet COSAR, Zehra ARIKAN, Asli KURUOGLU

Antipsychotics: Neurobiological bases for a therapeutic approach

Klinik Psikofarmakoloji Bülteni

Salih GUMRU, Feyza ARICIOGLU

Usual erratic phenomenon, dramatic outcome: A case report of phenytoin toxicity

Klinik Psikofarmakoloji Bülteni

Madhusudan Singh SOLANKI, Kuldip KUMAR

Persistent Hiccups after switching from zuclopenthixol to aripiprazole

Klinik Psikofarmakoloji Bülteni

Ibrahim DUVARCI, Mustafa YILMAZ